usa_2_0234|ADPT|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
usa_2_0234|ADPT|1|Adaptive Biotechnologies Corp Total Current Assets (Quarterly) (USD)|Adaptive Biotechnologies Corp Cash and Short Term Investments (Quarterly) (USD)|Adaptive Biotechnologies Corp Inventories (Quarterly) (USD)|Adaptive Biotechnologies Corp Net PP&E (Quarterly) (USD)|Adaptive Biotechnologies Corp Goodwill and Intangibles (Quarterly) (USD)|Adaptive Biotechnologies Corp Total Liabilities (Quarterly) (USD)|Adaptive Biotechnologies Corp Total Current Liabilities (Quarterly) (USD)|Adaptive Biotechnologies Corp Total Long Term Liabilities (Quarterly) (USD)|Adaptive Biotechnologies Corp Total Deposits (Quarterly) (USD)|Adaptive Biotechnologies Corp Book Value (Quarterly) (USD)|Adaptive Biotechnologies Corp Retained Earnings (Quarterly) (USD)|Adaptive Biotechnologies Corp Treasury Stock (Quarterly) (USD)|Adaptive Biotechnologies Corp EV to Revenues|Adaptive Biotechnologies Corp EV to Earnings|Adaptive Biotechnologies Corp EV to Free Cash Flow|Adaptive Biotechnologies Corp EV to Assets (Quarterly)|Adaptive Biotechnologies Corp PS Ratio|Adaptive Biotechnologies Corp PE Ratio|Adaptive Biotechnologies Corp Price to Book Value|Adaptive Biotechnologies Corp PEG Ratio|Adaptive Biotechnologies Corp Debt to Equity Ratio|Adaptive Biotechnologies Corp Dividend Yield|Adaptive Biotechnologies Corp Shareholder Yield (TTM)|Adaptive Biotechnologies Corp Percent of Shares Outstanding Short|Adaptive Biotechnologies Corp Total Receivables (Quarterly) (USD)|Adaptive Biotechnologies Corp Total Payables (Quarterly) (USD)|Adaptive Biotechnologies Corp Total Capital Stock (Quarterly) (USD)|Adaptive Biotechnologies Corp Return on Invested Capital|Adaptive Biotechnologies Corp Quality Ratio Score|Adaptive Biotechnologies Corp Momentum Score|Adaptive Biotechnologies Corp Beta (1Y)|Adaptive Biotechnologies Corp Sustainable Growth Rate (TTM)|Adaptive Biotechnologies Corp Institutional Investor Ownership Percentage|Adaptive Biotechnologies Corp Average Diluted Shares Outstanding (Quarterly)|Adaptive Biotechnologies Corp Total Employees (Annual)|Adaptive Biotechnologies Corp EPS Diluted (Quarterly) (USD)|Adaptive Biotechnologies Corp Shares Outstanding|Adaptive Biotechnologies Corp Repurchase of Capital Stock (Quarterly) (USD)|Adaptive Biotechnologies Corp Ordinary Shares Number (Quarterly)|Adaptive Biotechnologies Corp Payout Ratio|Adaptive Biotechnologies Corp Quick Ratio (Quarterly)|Adaptive Biotechnologies Corp Normalized Diluted EPS (Quarterly) (USD)|Adaptive Biotechnologies Corp Stock Buybacks (Quarterly) (USD)|Adaptive Biotechnologies Corp Effective Tax Rate (TTM)|Adaptive Biotechnologies Corp Return on Equity|Adaptive Biotechnologies Corp Net Income (TTM) (USD)|Adaptive Biotechnologies Corp Revenue (TTM) (USD)|Adaptive Biotechnologies Corp Dividend Per Share (Quarterly) (USD)|Adaptive Biotechnologies Corp Revenue (Quarterly) (USD)|Adaptive Biotechnologies Corp Gross Profit (Quarterly) (USD)|Adaptive Biotechnologies Corp SG&A Expense (Quarterly) (USD)|Adaptive Biotechnologies Corp Pre-Tax Income (Quarterly) (USD)|Adaptive Biotechnologies Corp Net Income (Quarterly) (USD)|Adaptive Biotechnologies Corp Net Interest Income (Quarterly) (USD)|Adaptive Biotechnologies Corp Price (USD)|Adaptive Biotechnologies Corp Total Return Price (USD)|Adaptive Biotechnologies Corp Enterprise Value (USD)|Adaptive Biotechnologies Corp 30-Day Average Daily Volume|Adaptive Biotechnologies Corp 1 Year Price Returns (Daily)||
usa_2_0234|ADPT|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
usa_2_0234|ADPT|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|daily|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
usa_2_0234|ADPT|5|91.1666666667|91.1666666667|91.1666666667|91.1666666667|91.1666666667|91.1666666667|91.1666666667|91.1666666667||91.1666666667|91.1666666667||1.44047619048|91.5|1.44047619048|91.5|1.44047619048||1.44047619048|1.45967741935|91.1666666667|1.4447761194|91.5|15.3333333333|91.1666666667|91.1666666667|91.1666666667|91.3333333333|91.5|30.5|30.6666666667|91.3333333333|30.5|91.3333333333|275|91.3333333333|28.6428571429||91.1666666667|91.1666666667|91.1666666667|91.3333333333|91.4||91.3333333333|91.1666666667|91.1666666667||91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.4447761194|1.4447761194|1.44047619048|1.44444444444|1.41463414634||
usa_2_0234|ADPT|6|6|6|6|6|6|6|6|6||6|6||336|4|336|4|336||336|124|6|335|4|30|6|6|6|3|4|2|3|3|14|9|1|9|14||6|6|6|9|5||3|6|6||9|9|9|9|9|9|335|335|336|306|82||
usa_2_0234|ADPT|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
usa_2_0234|ADPT|201803||||||||||||||||||||||||||||||||||105.8807||-0.117||||||-0.117|||||||9.715|5.726|9.59|-12.391|-12.391|0.747|||||||
usa_2_0234|ADPT|201806||||||||||||||||||||||||||||||||||105.8807||-0.118||||||-0.118|||||||11.568|6.524|9.961|-12.493|-12.493|0.82|||||||
usa_2_0234|ADPT|201809||||||||||||||||||||||||||||||||||105.8807||-0.0784||||||-0.0783|||||||17.188|11.828|10.778|-8.292|-8.292|0.869|||||||
usa_2_0234|ADPT|201812|180.718|165.018|7.838|19.125|132.598|590.8|22.8|568||-258.112|-295.908||||||||||||||4.807|1.793|0.001|||||||105.8807||-0.1244|||123.2242||7.4485|-0.1253||||-46.447|55.663||17.192|11.917|14.566|-13.271|-13.271|0.873|||||||
usa_2_0234|ADPT|201903|459.148|440.44|7.855|21.184|132.179|326.486|63.251|263.235||288.098|-314.548||||||||||||||4.066|3.266|0.011|||||||120.9742|346|-0.1541|||120.9742||7.0277|-0.152||||-52.442|58.614||12.666|7.678|14.821|-18.386|-18.386|1.659|||||||
usa_2_0234|ADPT|201906|442.301|423.001|8.004|22.298|131.756|885.769|74.862|810.907||-284.374|-330.917||78.3426|-97.4689|23.0465|9.0125|60.3916|||||||1.1624|7.252|2.944|0.001||3||||68.2066|13.2793||-1.23|120.9742||123.2242||5.7473|-1.23||||-55.608|69.184||22.138|16.404|15.559|-15.659|-15.659|0.446|48.3|48.3|5420.0529|380028.1333||38.55|50.85
usa_2_0234|ADPT|201909|601.356|573.428|8.667|46.542|131.328|331.467|73.377|258.09||585.925|-344.867||41.8677|-53.3402|15.1654|3.5622|36.0666||6.5561||||-8.3525|1.9913|9.257|2.421|0.012|-73.9175|2|||-73.9175|71.7375|124.2857||-0.11|124.3161||124.3161||7.941|-0.11|-320.85||-73.9175|-61.266|78.054||26.058|20.457|17.576|-13.95|-13.95|4.103|30.9|30.9|3267.9395|510143.9333||26.065|27.19
usa_2_0234|ADPT|201912|612.69|576.866|9.069|60.355|130.9|341.263|78.313|262.95||571.039|-365.478||37.266|-46.2096|16.3244|3.475|33.7442||6.5619|-0.0642|||-8.5626|3.965|12.676|4.453|0.012|-38.0057|3|||-38.0057|79.4083|125.2381|453|-0.17|125.2381||125.2381||7.528|-0.17|||-38.0057|-68.606|85.071||24.209|18.258|20.829|-20.611|-20.611|3.577|29.92|29.92|3170.258|772592.0333||29.905|28.1
usa_2_0234|ADPT|202003|584.646|555.173|10.518|56.01|130.476|323.323|77.95|245.373||551.563|-396.788||31.746|-36.2935|-25.7964|3.386|28.9412||6.3774|-0.0583|||-9.1214|2.4325|9.382|3.895|0.012|-23.835|2|||-23.835|94.1656|126.0584||-0.25|126.6218||126.6218||7.2425|-0.25|||-23.835|-81.623|93.315||20.91|15.567|25.828|-31.726|-31.403|2.894|27.78|27.78|2962.3806|1271586.4333||32.01|38.7
usa_2_0234|ADPT|202006|599.521|570.38|10.536|64.452|130.053|324.883|93.422|231.461||529.939|-430.323||61.1248|-56.6194|-43.1083|6.5903|66.0052||11.7069|-0.0967|||-5.1717|2.23|7.914|3.686|0.012|-25.4591|3|7|0.564|-25.4591|97.5269|127.3836||-0.26|128.2338||128.2338||6.1901|-0.26|||-25.4591|-99.499|92.165||20.988|16.076|26.57|-35.016|-33.535|1.893|48.38|48.38|5633.5712|1129753.1667|0.1656|37.32|41.61
usa_2_0234|ADPT|202009|||||||||||||65.4616||-46.1668||66.3463||12.4611|||||3.8429||||||4|0.4459||98.8903||||||||||||||||||||||48.63|48.63|6033.2676|991054.6333|57.3786|49.5|